• Science
  • Pipeline
  • News
  • About
  • Careers
  • Contact
Camelid Nanobodies Poised to Revolutionize Antibody Therapeutics

Camelid Nanobodies Poised to Revolutionize Antibody Therapeutics

by admin | Aug 26, 2020 | Press Release

Lysins Unlimited: Phages’ Secret Weapon

Lysins Unlimited: Phages’ Secret Weapon

by admin | Aug 4, 2020 | Press Release

Spirulina platform Lumen large as firm bags series A, therapies and more ahead

Spirulina platform Lumen large as firm bags series A, therapies and more ahead

by admin | Aug 3, 2020 | Press Release

Read More
Seattle biotech startup Lumen Bioscience raises $11.2M to develop drugs using algae

Seattle biotech startup Lumen Bioscience raises $11.2M to develop drugs using algae

by admin | Aug 3, 2020 | Press Release

The financing allows Lumen Bioscience to continue developing technology that uses the algae spirulina to make biologics. Read More
Fred Hutch and Adaptive Biotechnologies vets raise $13M for biotech startup

Fred Hutch and Adaptive Biotechnologies vets raise $13M for biotech startup

by admin | Aug 3, 2020 | Press Release

Lumen is chasing the $1.5 billion market for natural colorants with technology that uses Spirulina.
« Older Entries
Next Entries »

Recent Post

  • Cognition Live Article on RePreve Trial
  • LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial
  • Preventive antimicrobials: A promising solution to antibiotic resistance
  • Image Credit: © bukhta79 | stock.adobe.comPreventive Biologics May Aid the Antibiotic Resistance Crisis
  • Q&A: Biologic drugs are reinvented to treat infectious diseases

Follow on

  • Follow
  • Follow
  • Follow

  • Science
  • Pipeline
  • News
  • About

  • Careers
  • Contact
  • Privacy Policy
  • PO Terms

  • Expanded Access Policy
  • FCOI
  • Services
  • iLumenate Newsletter

©2024 Lumen Bioscience, Inc.